
There's no one more deserving of this award, and I'm lucky to call him my friend. #mila2millions

Mila fought hard against Batten disease, a rare fatal condition with no cure. Her story is now giving new hope to millions with genetic disease.

There's no one more deserving of this award, and I'm lucky to call him my friend. #mila2millions

I've watched Tim fight tirelessly for my own daughter Mila, and since then for hundreds of others - not just his own patients, but countless children around the world who he's managed to find time in his incredibly busy life to help.

It was great to have the Oligonucleotide Therapeutics Society (OTS) annual meeting this year so close to home in Denver, Colorado, and have the chance to surprise Tim Yu on stage as Annemieke Aartsma-Rus presented him with this year's Patient Advocacy award.

This week, Janet published a great article in BioCentury Inc. laying out five reforms within the FDA’s current authority that could make individualized therapies commercially viable. My hope is that the FDA acts on these. ARTICLE: biocentury.com/article/66130… #mila2millions

In my mission to scale access to individualized medicines and get from Mila to Millions, I've been incredibly fortunate to work closely alongside Janet Woodcock.

Apply by Friday, Nov. 13 If this sounds like you, or someone you know, please reach out or share! #Hiring #RareDisease #mila2millions

MMF is a small, remote nonprofit with a big mission: advancing the new field of individualized medicine that Mila opened up. Every hour of this role keeps that mission moving forward. JOB DESCRIPTION - milasmiracle.org/job-opening…

We’re hiring a part-time, temporary Operations Coordinator to run day-to-day operations December-April, coordinate campaigns, handle donor communications, and serve as the main point of contact for our board, partners, and supporters.

Looking for a part-time team member! For almost 10 yrs, Maggie Spoth has been my partner-in-crime behind the scenes a MMF, nearly since day one. Now she’s about to welcome her first child (congrats, Maggie!), and we need someone great to keep things running while she’s on leave.


Last month, I spoke with Grace Hampson & Amanda Cole from the @OHENews on their podcast 'A Dose of Economics' on the critical topics beyond regulation, on what HTA bodies and payers also need to change to bring individualised medicines to more patients.

That effort led to the RTLP and an initial focus on the regulatory path. The MHRA's recent Rare Disease Therapies Regulatory Framework opens up the opportunity we've been pushing for. Yet there is still much work to be done to see exponentially more children treated.

Four years ago, I came to the UK with a belief that we could demonstrate a new, scalable way for patients like Mila to access the incredible science available today through individualised genetic medicines.

So the next Mila's can be found and treated in time so that they and their families never know life with disease. #mila2millions

Chloe, Dana, Arran, Tiziana, and Tomas represent who we are fixing the system for - to help patients, the next generation of new doctors and scientists must find a changed system in place that ensures that every child in need can access today's incredible science.

And then I looked ahead to ten years from now when Mila's friends - a number of whom were inspired by her to be doctors and scientists - will be working in this field, trying to help the millions of children who follow.